Dr. Karin Hollerbach is a Senior Consultant at the US Market Access Center. Dr. Karin Hollerbach serves as CEO of Taku Group. Taku Group helps global wellness companies accelerate growth and capitalize on market opportunities. Taku Group's clients move to their next level of growth - by raising growth capital, entering new markets, or expanding via strategic alliances. Dr. Hollerbach has served as CEO, President, Executive Vice President, VP of Technology, VP of Products, and other management roles. She has served in interdisciplinary roles at Lawrence Livermore Laboratory, the Whitehead Institute, SRI, and Draper Laboratory. 

Dr. Hollerbach holds undergraduate degrees in Molecular Biology and in EECS from the Massachusetts Institute of Technology, an MSEE from UC Berkeley, and a PhD in Biomedical Engineering awarded by UC Berkeley and UCSF. She serves as President and Director of the M.I.T. Club of Northern California, serving over 8,600 M.I.T. alumni and alumnae, and as Trustee of St. Mary's Medical Center in San Francisco, where she chairs the Board Development Committee. Dr. Hollerbach is an active alumna of Leadership America. She is fluent in multiple languages.